MEDTIDE INCMEDTIDE INCMEDTIDE INC

MEDTIDE INC

No trades
See on Supercharts

3880 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Medtide, Inc. is a peptide focused contract research, development and manufacturing organization. It services include contract research organization services, namely peptide new chemical entity discovery synthesis, contract development and manufacturing organization services, namely peptide chemistry, manufacturing and controls development, and contract manufacturing organization services, namely peptide NCE and generic drug commercial manufacturing. The company was founded by Li Xiang and Xu Qi on June 11, 2020 and is headquartered in Hangzhou, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
3880 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company